This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through March 4, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
5 Dividend-Paying Multiline Insurers Worth Watching
by Tanuka De
Multiline insurers like MetLife (MET), Prudential Financial (PRU), MGIC Investment (MTG), CNO Financial (CNO) and Old Republic (ORI), which have a solid dividend history, offer a breather amid volatility.
Here's Why You Should Retain PRA Group (PRAA) Stock for Now
by Zacks Equity Research
Growing portfolio supply in the United States, coupled with pricing tailwinds and improvement in cash efficiency ratio, poise PRA Group (PRAA) well for growth.
Should Value Investors Buy CNO Financial Group (CNO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why CNO Financial (CNO) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Here's Why CNO Financial (CNO) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Compelling Reasons to Retain Intercontinental (ICE) Stock Now
by Zacks Equity Research
Intercontinental (ICE) gains from a compelling portfolio, expansive risk management services, strategic buyouts, solid balance sheet and effective capital deployment.
MGIC Investment (MTG) Up 62.6% in a Year: More Room to Run?
by Zacks Equity Research
MGIC Investment (MTG) gains on the back of solid insurance in force, a decline in loss and claims payments, lower delinquency, better housing market fundamentals and prudent capital deployment.
Assurant (AIZ) Rises 57.6% in a Year: Will the Rally Last?
by Zacks Equity Research
Assurant (AIZ) gains on the back of a well-performing Global Lifestyle business, growth of fee-based capital-light businesses, favorable estimates and financial flexibility.
Factors That Make CNO Financial (CNO) a Lucrative Bet Now
by Zacks Equity Research
CNO Financial (CNO) remains well-poised for growth on a diversified product portfolio, technology investments and sustained record to return value to shareholders.
Key Highlights From CNO Financial's (CNO) Optavise Report
by Zacks Equity Research
CNO Financial's (CNO) Annual Benefits Broker Survey highlights the growing requirements of broker partners to address employers' regulatory and compliance management concerns.
Why You Should Retain American International (AIG) Stock Now
by Zacks Equity Research
Rising premiums, cost control efforts, streamlining of operations and increasing rates poise American International (AIG) well for growth.
Intercontinental (ICE), Freddie Mac Join to Enhance Loan Quality
by Zacks Equity Research
Intercontinental (ICE) and Freddie Mac collaborate to improve loan quality and reduce defects in the loan origination process.
Sun Life (SLF) Expands Family Leave Insurance Product in Florida
by Zacks Equity Research
Sun Life (SLF) bridges the gap of funding for small-size and mid-size firms, which enable them to provide paid family leave for their employees.
Are Investors Undervaluing CNO Financial Group (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Compelling Reasons to Hold on to Marsh & McLennan (MMC) Stock
by Zacks Equity Research
Marsh & McLennan (MMC) gains from strong segmental contribution, better rate hikes and solid growth in operating cash flows.
CNO Financial (CNO) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
Strength Seen in James River Group (JRVR): Can Its 17.5% Jump Turn into More Strength?
by Zacks Equity Research
James River Group (JRVR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Should You Hold EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) stands to gain from reduced operating expenses, revenue growth within the health direct-to-consumer agency and a robust capital position.
Why Is American International Group (AIG) Up 9.1% Since Last Earnings Report?
by Zacks Equity Research
American International Group (AIG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reasons to Hold Prudential Financial (PRU) in Your Portfolio Now
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from growing pension risk transfer market, higher emerging markets earnings, improved spread income, strategic acquisitions and effective capital deployment.
Here's Why Investors Should Retain Everest Group (EG) Stock
by Zacks Equity Research
Everest Group (EG) stands to gain from an improved interest rate environment, strong renewal retention, continued favorable rate increases and a solid capital position.
Why Is CNO (CNO) Down 2.2% Since Last Earnings Report?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Buy CNO Financial Group (CNO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Marsh & McLennan's (MMC) Mercer SelectRx to Lower Pharmacy Spend
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit Mercer launches a tech-enabled solution to generate higher cost savings for employees on specialty drugs and subsequently, drive its revenues.